071sek
-12,3 %
Date:2025-05-13Time:18:00:00Latest report:Q4-2024List:First NorthTicker:SPEC
Market Cap:69 msekEnterprise Value:56 msekNet Sales:- msekEarnings:-23,0 msekEmployees:0ISIN:SE0007158118

Ratios

10-year key figure history for SpectraCure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SpectraCure with index and moving average MA50 and MA200.

Stockprice:0,71
MA50:1,63
MA200:2,03
Price/MA200:-65,1 %
RSI (14):21,8
Price/MA50:-56,3 %

Description

SpectraCure is a medical technology company The company specializes in the research and development of medical technology systems used to treat prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internally solid tumors of various types. The company operates in the Nordic market. The head office is located in Lund.

Medical Equipment